INTRODUCTION
Glycosylation is a common modification of proteins. In the CNS, glycans mainly act as modulators of protein function. They support or inhibit the activation of membrane receptors and control cell-cell or cell-matrix interactions. Moreover, due to their distinct spatiotemporal expression, glycans serve as excellent biomarkers. They allow the identification of subpopulations of cells at defined differentiation stages (1, 2) .
A glycan biomarker, utilized to identify and isolate neural stem/progenitor cells (NSPCs) 4 , is LewisX (3) . LewisX (LeX), also known as CD15 or stage specific embryonic antigen-1 (SSEA-1), is a glycan motif associated with glycoproteins and glycolipids. Throughout neurogenesis, LewisX is present on radial glia which represent the neural stem cell population in the developing embryonic cortex (4, 5) . Anti-LeX antibodies are routinely used to isolate NSPCs from embryonic and adult mouse brains as well as for the purification of neural stem cells after differentiation of human ES cells (2, 4, 6) . However, the functional relevance of LeX-glycans in vivo is not well investigated. In vitro data proposes that LeX-glycans are involved in migration, proliferation and maintenance of stemness (7) (8) (9) .
Glycosylation varies dramatically depending on the tissue, cell type or time point of investigation.
Also predictions on what proteins are glycosylated in vivo based on in vitro data is difficult. Using various protein sources a number of LeX carrier proteins has been identified, including Phosphacan, the secreted splice variant of the protein tyrosine phosphatase receptor-type zeta (Ptprz1), the extracellular matrix protein Tenascin-C, L1-cell adhesion molecule (L1-CAM), β1-integrin, lysosomal-associated membrane protein (LAMP-1), CD24 and Thy-1 [tabularization in (3) ]. However, a systematic analysis of LeX glycoproteins present during CNS development has not been performed so far. LeX carriers in vivo need to be specified that would allow studying LeX function in a protein dependent context.
In this study, we used anti-LeX antibodies to isolate glycoproteins from mouse CNS tissue at neurogenic and gliogenic developmental stages. Firstly, this allowed us to further specify the LeX glycosylated proteins expressed in vivo. Secondly, the identification of LeX carrier proteins present during critical developmental periods was aimed at detecting glycoproteins that are important for neural stem cell biology and CNS development. In this context, we present LRP1 as a novel LeX glycosylated protein in the early CNS. Finally, we reveal the importance of LRP1 for neural stem cell differentiation by demonstrating that Lrp1 knockout NSPCs are impaired in their capacity to generate oligodendrocytes.
EXPERIMENTAL PROCEDURE
Antibodies-Antibodies are listed in Supplemental Table 2 .
Animals-Lrp1 flox/flox mice (10) were obtained from the Jackson laboratories (B6;129S7-Lrp1 tm2Her /J) and kept on a CL57/B6 (Charles River, Sulzfeld, Germany) background. Except for Lrp1 knockout studies, mice of the NMRI strain (Charles River) were used. All animals were housed under standard conditions on a 12h light/dark cycle with access to water and food ad libitum. The day of the vaginal plug was considered as embryonic day 0.5 (E0.5).
Cultivation of NSPCs-Acutely dissociated cells were obtained from cortices of E14.5 embryos as previously described (5) . For the cultivation of NSPCs as neurospheres, 100,000 cells/ml were plated in NSPC medium [DMEM/F12 (1:1), 0.2 mg/ml L-glutamine (all Sigma, Munich, Germany), 2% (v/v) B27, 100 U/ml penicillin, 100 µg/ml streptomycin (all Invitrogen, Karlsruhe, Germany)] supplemented with 20 ng/ml EGF, 20 ng/ml FGF2 (all Peprotech, Rocky Hill, USA) and 0.5 U/ml heparin (Sigma).
Cre protein transduction-Recombinant HTNCre fusion protein (11) was expressed from pTriEx-HTNC and purified as described previously (12) . For transduction, neurospheres from Lrp1 flox/flox mice or their wildtype littermates were dissociated using 0.05% (v/v) Trypsin-EDTA (Invitrogen) and 50,000 cells were plated on polyornithin (15µg/ml, Sigma) and Laminin (2 µg/ml, BD Bioscience, Erembodegem, Belgium) coated 16 mm dishes (Nunc, Wiesbaden, Germany) in NSPC medium supplemented with 10 ng/ml EGF and FGF2 overnight. The next day, the cells were incubated in NSPC medium containing 20 ng/ml growth factors and 0.5 µM Cre recombinase for 8-15 hours (12). 24 h after Cre treatment the cells were removed from the dish by trypsinization and cultivated as free-floating neurospheres.
Neural stem cell differentiation assay-Cre treated NSPCs were plated on poly-ornithine and Laminin (5 µg/ml) coated dishes at a density of 30,000 cells /cm 2 in NSPC medium supplemented with 1% (v/v) FCS (Invitrogen) for 7d. For some experiments single cells derived from 2nd or 3rd passage NMRI mice neurosphere were differentiated in the presence of 50 µg/ml immunopurified mAb 487
LeX , 75 µM RAP or 75 µM GST for 7d. Medium and additives were replaced every 2nd day.
Membrane Preparation-The separation of membrane and soluble proteins from mouse tissue was performed as previously described (13) . The membrane pellet was washed with 0.1 M Na 2 CO 3 pH 11 for 30 min and centrifugation at 100,000 g was repeated. The membrane pellet was lysed in buffer C (20 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA) supplemented with 1% (v/v) Triton-X-100 over night. Insoluble material was removed at 2000 g for 20 min. Before chromatography, the lysate was diluted to 0.5% (v/v) Triton-X-100.
Immunoaffinity Chromatography-Rat IgMs were purified from hybridoma supernatants as described (14) and coupled to Cyanogen bromideactivated-Sepharose 4B according to the manufacturer's instructions (Amersham, Freiburg, Germany). Cleared membrane lysates were circulated over an isotype-matched control column (4860, rat IgM against a glycan-epitope associated exclusively with lipids, not with proteins (15)), followed by anti-LeX mAbs 5750
LeX (5) and 487
LeX (16) affinity columns for at least 48 h with a flow rate of 0.5 ml/min. Each column was washed with 30 volumes buffer C + 0.1% (v/v)Triton-X-100; 10 volumes buffer C + 0.1% (v/v) Triton-X-100 + 0.5 M NaCl and 10 volumes buffer C+0.1% Triton-X-100 at 2 ml/min. Before elution 2 volumes buffer C+3 mM n-dodecyl-β-Dmaltoside were passed over the column. The bound protein was eluted with 2 volumes elution buffer pH 11.5 (100 mM NaCl, 100 mM diethylamine, 1 mM EDTA, 1 mM EGTA, 3 mM n-Dodecyl-β-D-maltoside). All washing buffers contained protease inhibitors (1 mM PMSF, 100 µM iodoacetic acid, 10 mM N-ethylmaleimide, 2 mM benzamidine, 1 mM α-aminocaproic acid). The eluate was neutralized with 1 M HCl, adjusted to 20 mM Tris and concentrated in centricon centrifugal filter units (Millipore) with a 75 kDa molecular mass cut off.
1D-nLC-ESI-MS/MS-For
in-solution digestion, 200 µg protein were TCA precipitated, reconstituted in 8 M urea/100 mM Tris pH 8, reduced and alkylated sequentially using 5 mM tris(2-carboxyethyl)phosphine and 10 mM iodoacetic acid for 20 min. Proteins were digested with 0.01 µg/µl Trypsin (Promega, Madison, USA) in 20 µl 2 M Urea/100mM Tris pH 8 overnight at 37°C. Samples were desalted using C 18 solid phase extraction tips (Varian, Lake Forest, USA). For in-gel digestions (17) , gel pieces were excised, destained using 25 mM NH 4 HCO 3 , 50% (v/v) acetonitrile and digested with 12.5 ng/µl Trypsin in 25 mM NH 4 HCO 3 , followed by sonication in 50% acetonitrile, 0.5 % (v/v) TCA. Protein detection via 1D-nLC-ESI-MS/MS on an LTQ Orbitrap was performed as previously described (18) . Raw data files were searched against the Mus musculus NCBI database using SEQUEST algorithm embedded in Bioworks 3.3.1 SP1 (Thermo Fisher Scientific, Waltham, MA, USA). Mass accuracy was set to 10 ppm for precursor ions and 1 amu for fragment ions. Only tryptic peptides with at most 2 missed cleavage sites were accepted. Oxidation of methionine and alkylation (carbamidomethylation) of cysteine were admitted as peptide modifications, glycosylation modifications were not taken into account. Results were filtered according to peptide and protein probability (< 0.001), requiring at least two different peptides per protein.
Immunoprecipitation-For precipitation of LeX glycoproteins 20 µl Protein A/G agarose slurry (Santa Cruz, Hamburg, Germany) was incubated with 2.5 µg unconjugated goat anti-rat IgM for 4 h on a rotating wheel in PBS, followed by incubation with 5750
LeX rat IgM antibody or isotype control for 2 h in 1 ml PBS/A. The beads were then incubated overnight with 500 µg protein lysate in 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% (v/v) Triton X-100, 0.1% (v/v) Na-deoxycholate, 0.1% (v/v) SDS, and washed 5 times. All buffers contained 1 mM PMSF and 2 µg/µl Aprotinin. Before SDS-PAGE samples were boiled in loading buffer (60 mM Tris-HCl pH 6.8, 2.5% (v/v) SDS, 10% (v/v) glycerol, 5% (v/v) β-mercaptoethanol, 0.01% (w/v) bromophenol blue). For co-precipitation of LRP1 α and β chain, 4 µl anti-LRP1 rabbit IgG and Co-IP buffer (30 mM Tris/HCl pH 7.4, 150 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2 , 1% (v/v) Triton X-100) were used. N-glycanase F (EC 3.5.1.52) digestion was performed as previously described (5) . For the precipitation of LRP1 using the receptor associated protein (RAP) as ligand, full length mouse RAP was cloned into pGEX4T1 (Amersham). The RAP-GST fusion protein was expressed in E.coli and purified via its GST tag according to standard protocols. 50 µg RAP-GST or GST alone were coupled to 20 µl of Glutathione-Sepharose 4B (Amersham) and incubated with protein lysate in GST-buffer (50 mM Tris, pH 7.4, 100 mM NaCl, 2 mM MgCl 2 ,
Western Blot Analysis-Western blots were performed according to standard protocols as outlined in (5) .
Immunochemistry-Immunohistochemistry was performed as previously described (5) with the following modifications: Cryosections were rehydrated and blocked in PBS containing 10% (v/v) FCS and 0.2% (v/v) Triton-X-100. For the detection of Ctip2, antigen retrieval was performed by boiling the sections for 5 min in citrate buffer pH 6. For immunocytochemistry refer to (15) .
Documentation and Data Analysis-Images were taken with the Axioplan2 Axiovision Software (Zeiss, Jena, Germany). For the quantification of O4-positive cells at least 1500 cells were counted per condition in at least 4 independent experiments. Statistical significance was assessed using the paired two-sample t-test.
RESULTS
LeX carrier proteins change from embryonic towards postnatal CNS development-In order to investigate the expression of LeX glycoproteins in the course of CNS development, we first performed a Western blot analysis of embryonic (E10, E13, E15, E18) and postnatal (P1, P4, P10, P15) mouse brains. When we examined LeX in brain tissue lysates using Western blots, we detected three distinct protein bands at E13 and E15, whereas only one was detectable at P15 ( Figure 1A ). Next we compared tissue from E14 cortex and ganglionic eminence (GE). The main LeX carrier protein detected in cortical tissue had a lower molecular weight than the major carrier protein in ganglionic eminence ( Figure 1B ). This suggested that depending on the time point and tissue investigated, different sets of proteins are LeX glycosylated. To test whether indeed different LeX carrier proteins can be distinguished, we separated membrane proteins from the membraneindependent fraction containing extracellular matrix and cytosolic proteins. In lysates from E13 mouse brain, the LeX-glycan was detected primarily on membrane proteins. In contrast, at P12, LeX-positive proteins predominated in the membrane-free fraction ( Figure 1C ). This suggests that the LeX-glycan distribution shifts from an association with membrane proteins during embryonic development towards an attachment to secreted extracellular matrix (ECM) proteins at later developmental stages. Furthermore, we investigated LeX expression by immunohistochemistry.
Immunohistochemical stainings of coronal forebrain sections at E12.5 showed that LeX expression was very prominent within the embryonic cortex ( Figure 1D,E) , which is in accordance with previous publications (4, 5) . In extension of these reports we noted that the staining pattern for LeX changed as development proceeded. Immunostaining of a P1 coronal forebrain section revealed a more diffuse LeXexpression in the cortex and the anterior septum. Prominent LeX immunoreactivity at later stages remained detectable exclusively in the stem cell niche microenvironment at the lateral ventricle, in particular the medial wall of the septum and in the subcallosal zone ( Figure 1F,G) .
Thus, in contrast to other stem cell marker molecules, LeX expression did not vanish during postnatal development. Instead, it shifted from membrane towards soluble proteins of the ECM. This observation prompted us to further specify the LeX-carrier proteins expressed in vivo.
LeX-glycans are associated with Ptrpz1, L1-CAM, Tenascin-C and LRP1-To identify LeX carrier proteins expressed during critical developmental periods, we isolated LeX-positive proteins by immunoaffinity chromatography from embryonic (E13-16) and postnatal (P7-14) mouse brains. These time points correspond to neurogenic and gliogenic developmental phases, respectively. We previously reported that individual anti-LeX mAbs exhibit differences in their affinity towards LeX-containing glycans (5). Therefore we here used two different antibody clones for our analysis, mAbs 5750
LeX and 487 LeX , with the intention to capture a broad spectrum of LeX-containing glycans. The detailed LeXstructures detected by theses mAbs have been previously characterized by glycan array (5).
Since many glycosylated proteins do not focus in distinct bands following SDS-PAGE, we performed a gel-free analysis of the immunopurified protein samples ( Figure 2B ). In total, 4 independent samples purified from embryonic brain and 3 samples from postnatal brain were analysed. To verify that LeX proteins were truly enriched via our immunoaffinity purification strategy, we first looked at three LeX glycosylated proteins that have been previously identified as carriers of LeX-glycans: Phosphacan, an isoform of the Ptprz1 gene, Tenascin-C and L1-CAM. Ptprz1, Tenascin-C and L1-CAM peptides could be detected in all samples from postnatal brain. However, Ptprz1 was not detected in embryonic samples and Tenascin-C and L1-CAM were detected only in 2 out of 4 samples from embryonic brain ( Figure 2B ). This correlated with the expression of these glycoproteins which was higher during postnatal development (data not shown). Peptides corresponding to the Ptprz1 gene locus, were only found in samples from postnatal brain. A distinction between the different Ptprz1 isoforms was not possible, because the detected peptides were localized within the first 400 amino acids of the protein which is common to all 4 isoforms of the Ptprz1 gene including membrane bound and secreted splice variants. In the isotype control sample Tenascin-C, L1-CAM and Ptprz1 were not detected, demonstrating that LeXpositive proteins could be enriched successfully.
Next, we screened the list of identified proteins for membrane associated proteins with a molecular mass of >100 kDa, which corresponds to the molecular range where we detected the strongest LeX signals in the Western blot. We found that the low density lipoprotein receptor-related protein 1 (LRP1) was enriched in both embryonic and postnatal protein samples. LRP1 is a glycosylated membrane protein with an apparent molecular mass of more than 600 kDa. In Supplemental Table 1 the LRP1 peptides detected in a sample prepared from embryonic brain are listed.
In addition to the gel-free analysis, samples were also analysed after one-dimensional SDS-PAGE ( Figure 2C,D) . With this approach, two distinct protein bands could be assigned to LRP1 and Tenascin-C.
So far, LRP1 expression has been described for various cell types including fibroblasts, schwann cells, neurons and glia (19) (20) (21) . However, NSPCs are the main source of LeX immunoreactivity in the early developing CNS (4, 5) . Therefore, we reasoned that LeX glycoforms of LRP1 could be expressed by NSPCs. Further experiments were performed to confirm this hypothesis.
LeX glycoforms of LRP1 are expressed by NSPCs-To the best of our knowledge, Lrp1 expression in the developing cortex has not been investigated in detail so far. Lrp1 gene knockout, however, is lethal at the stage of embryo implantation, leaving unanswered whether Lrp1 is of functional relevance for CNS development (22) . Thus, we firstly studied LRP1 expression in the developing CNS. Immunohistochemical stainings against LRP1 on cryosections of mouse embryos showed that LRP1 immunoreactivity was detectable in the ventricular zone at E12.5. Double labelling with LeX revealed an overlap of LRP1 on cells near the ventricle, as well as in the hippocampal anlage and the diencephalon ( Figure  3A,B) , presumably radial glia. LRP1 expression partially overlapped also with Nestin which suggests that LRP1 is indeed expressed by undifferentiated NSPCs (Figure 3C ). At E14.5 LRP1 expression was upregulated in the cortical plate, where Ctip2-positive deep layer neurons accumulate, but remained also present in the ventricular and subventricular zone ( Figure 3D ). Next, we stained acutely dissociated cells obtained from E14.5 cortices against LRP1 and the stem cell markers LeX and Nestin ( Figure 3E,F) . Double stainings revealed that LRP1 was expressed by LeX-and Nestin-positive cells, however, not exclusively. Towards the end of neurogenesis, LRP1 was detectable throughout the cortex. Expression was pronounced in the marginal zone near the pial surface as well as adjacent to the lateral and dorsal wall of the lateral ventricles and the choroid plexus ( Figure 3G,H) . At the dorsal and medial wall of the lateral ventricle, LeX immunoreactivity overlapped with prominent LRP1 expression ( Figure 3I ).
To investigate whether LeX and LRP1 are merely co-expressed on NSPCs or if LRP1 is indeed LeX glycosylated, we performed immunoprecipitations. We analysed protein lysates from NSPCs cultivated as neurospheres. In contrast to blots of postnatal whole brain tissue where LeX immunoreactivity ran as a broad smear (Figure 1 A-C, Figure 4E ), LeX carrier proteins from NSPC lysates gave rise to multiple more distinct signals. This resembled more closely the western blot signals seen in embryonic brain lysates ( Figure 1A ). To confirm that NSPCs express LeX carrying glycoforms of LRP1, an immunoprecipitation with anti-LeX mAb 5750 LeX was performed ( Figure 4B ). The Western blot with anti-LRP1 β-chain specific antibody confirmed that LRP1 was successfully precipitated from NSPC lysates along with other LeX carrier proteins. In the reverse experiment anti-LRP1 β-chain antibody was used to co-precipitate LRP1 α and β chain from NSPC protein lysates ( Figure  4C) . A single LeX-positive protein band above 500 kDa was detected ( Figure 4C ). Its size correlated with the expected size of the α-chain of LRP1, indicating that mainly the LRP1 α-chain carried the LeX-glycans. [Note that the mature LRP1 protein consists of two non-covalently linked subunits, a 515 kDa α-chain and a 85 kDa β-chain, which run as separate protein bands in the Western blot ( Figure 4A) ]. Next, we directly precipitated LRP1 α-chain from NSPC and P1 protein lysates using RAP as a ligand. RAP binds to extracellular domains of LDL-receptor family members, including LRP1 and LRP2. When using RAP for precipitation, Western blotting again demonstrated the presence of LeX in NSPC and P1 mouse brain lysates ( Figure 4D,E) . Probing against the human natural killer antigen-1 (HNK-1) revealed that other functionally relevant glycan motifs are attached to the precipitated protein backbone in addition to LeX ( Figure 4E ). To further specify whether LeX and HNK-1 glycans are N-linked to LRP1, we cleaved N-linked sugars from the protein core by using protein Nglycosidase F. This resulted in complete removal of LeX and HNK-1 immunoreactivity ( Figure 4F ). Thus, we conclude that LeX and HNK-1 glycans are N-linked to LRP1 α-chain.
LRP1 promotes the generation of oligodendrocytes-Since LRP1 expression seemed to be regulated in a spatiotemporal manner, we were interested, whether LRP1 is also involved in the regulation of CNS development. To investigate the function of LRP1 we generated Lrp1 knockout NSPCs from Lrp1 flox/flox mice. We adapted previously published protocols based on cell-permeant Cre recombinase that result in recombination efficiencies of more than 90% (12) . The protocol is outlined in Figure 5A : NSPCs were derived from cortical tissue of Lrp1 flox/flox mice and Lrp1 wt/wt littermates and treated with Cre recombinase to induce recombination leading to deletion of Exon 1 of the Lrp1 gene (10) . Recombination could be verified by PCR ( Figure  5B,C) . Lrp1 knockout NSPCs proliferated and could be maintained in EGF and FGF2 as neurospheres ( Figure 5D ). LRP1 protein was barely detectable in Lrp1 knockout NSPC cultures, also after several weeks of cultivation ( Figure  5E,F) . This indicated that incompletely recombined cells did not overgrow the culture upon passaging. Lrp1 knockout NSPCs retained the capacity to differentiate into all major neural cell types (Figure 5G-J) . In general, Lrp1 does not seem to be necessary for stem cell proliferation and maintenance of stemness in the neurosphere model. However, upon differentiation, Lrp1 knockout NSPCs generated 3-times less oligodendrocyte precursor cells, as identified by O4 staining, in comparison to Lrp1 wt/wt cells (Lrp1 flox/flox 0.69% ± 0.10%; Lrp1 wt/wt 2.53% ± 0.46%, p = 0.004, Figure 6A-E) . This suggests that Lrp1 supports differentiation towards an oligodendroglial cell fate. To address whether LRP1 function is dependent on LeX glycosylation, we blocked LeX-glycans by adding mAb 487
LeX to the cell culture medium. This approach has previously been show to effect cell migration and process formation (7, 23) . However, the number of O4-positive cells was not significantly altered upon differentiation in the presence of mAb 487
LeX (487 LeX : 2.79% ± 0.82%; control: 2.74% ± 1.03%; p = 0.70, Figure 6F ). In contrast, blocking the extracellular part of LRP1 by adding RAP to the cell culture medium resulted in a reduction of O4-positive cells. The difference, however, was not as dramatic as after complete Lrp1 knock-out (RAP: 1.23% ± 0.19%; control: 2.03% ± 0.42%, Figure 6G ). In conclusion, Lrp1 function in oligodendroglial lineage progression appears to be independent of LeX glycosylation.
In summary, using LeX-glycans as a biomarker we identified LRP1 as a novel LeX glycosylation target expressed by NSPCs. Our investigations provide first evidence for a functional role of LRP1 in neural stem cell differentiation.
DISCUSSION
Studies based on in vitro models demonstrate that LeX-glycans are involved in NSPC proliferation, migration and maintenance of stemness (7) (8) (9) . However, proof underlining the significance of LeX glycosylation in vivo is lacking. The identification of LeX carrier proteins present in the mouse CNS provides a first step towards understanding the role of LeX glycosylation in vivo. Our results propose that the glycoproteins Ptprz1, L1-CAM and Tenascin-C are major LeX glycosylation targets during postnatal development. Moreover, we characterized LRP1 as a new membrane associated LeX carrier protein on NSPCs which is involved in oligodendrogenesis.
Up to date, LRP1 function is well investigated in the context of myelin phagocytosis and Alzheimer's disease (21, 24) . Our data now proposes that LRP1 is additionally involved in CNS development and neural stem cell biology. However LRP1 may not be necessary for stem cell maintenance per se, as Lrp1 knockout NSPCs can be expanded in vitro and retain their ability to differentiate.
Nevertheless, oligodendrocyte lineage progression is severely impaired.
Since LRP1 is capable of interacting with more than 30 ligands (20) , there exist many scenarios how LRP1 could modify NSPC differentiation. LRP1 mediates endocytosis of various growth factors such as PDGF and TGFβ that are essential regulators of cell proliferation and differentiation in the CNS (25) . Recently, Gan et al reported that ApoE, an LDL-receptor family ligand, stimulates the formation of oligodendrocytes (26) . However, this study did not further specify the ApoE receptor involved. Our data now strongly suggests LRP1 as the receptor mediating this effect. Moreover, in addition to its role as ApoE receptor, it has been suggested that LRP1 can modulate Wnt signaling by binding to the Wnt co-receptor Frizzled (27) . Wnt signaling is an important regulator of the timing of oligodendrocyte precursor differentiation (28) . Additionally, LRP1 together with Thrombospondin-2 has been shown to stimulate Notch activity by trans-endocytosis (29) . Notch signaling is responsible for stem cell maintenance and gliogenic versus neurogenic fate choices (30) . Last but not least, LRP1 is also involved in lipid uptake, which could also affect cell differentiation upon Lrp1 deletion (20) . Which of the before mentioned pathways is responsible for LRP1 function during oligodendrocyte differentiation remains to be investigated in the future.
Interestingly, LeX-glycans are also involved in two of these pathways: Wnt and Notch signaling (4, 9) . The general abrogation of LeX-glycans by siRNA mediated knock-down of Fucosyltransferase 9 (Fut9) leads to a reduced expression of Numb and Hes5, downstream molecules in the Notch signaling pathway (9) . However, Fut9 knock-down experiments performed so far failed to demonstrate direct effects on cell specification. Also, by antibody mediated LeX epitope blocking we could not observe significant modifications of oligodendrocyte numbers in this study. Therefore, it remains unclear whether, apart from modulating cell proliferation (8, 9) , LeX-glycans also influence cell fate choices. The data rather suggests that the role of LRP1 during oligodendrogenesis is independent of LeX glycosylation.
Interestingly, we found only a sub-fraction of LRP1 to be LeX glycosylated. Glycosylation is a complex process whereby the expression of a specific set of glycosyltransferases and the availability of the individual sugar molecules results in the synthesis of a glycan chain. Hence, it is not surprising to detect different glycoforms of a protein depending on the developmental time point, tissue, and species where the protein is investigated. Remarkably, although glycosylation is highly variable, the LeX-glycan motif is conserved on neural stem cells also in other species. In humans, however, LeX-glycans appear exclusively upon neural differentiation. In mice embryonic stem cells express LeX already prior to neural lineage specification (31) .
In conclusion, our screen for LeX carrier proteins which led to the identification of LRP1, sheds new light on a well-known glycoprotein by suggesting a new role during CNS development. LeX or 5750 LeX were separated by SDS-PAGE and analysed by Western blot or silver staining. Prominent protein bands were excised from the gel and analysed via 1D-nLC-ESI-MS/MS. Note that some LeX carrier proteins such as Ptprz1 expose glycosaminoglycan chains and do not focus into distinct bands in SDS-PAGE. However, these constituents appear as high molecular smear on immunoblots. E: embryonic day, P: postnatal day 
